Oct 5 2009
Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that there was a successful auction sale of five drug program intellectual properties on September 30, 2009.
There were eleven (11) bidders who submitted seventeen (17) bids. The five (5) programs were sold to five (5) different companies.
The remaining intellectual property, regulatory dossier and clinical inventory will be sold at auction on October 7, 2009. The remaining programs are the PRX-03140 5HT4 partial agonist (phase 2 CNS clinical candidate, MCH antagonist (Lead Optimization) and NPS antagonists (Lead Optimization). In silico Modeling Technology will also be sold then.
Source:
Joseph F. Finn, Jr., C.P.A.